|
시장보고서
상품코드
2117701
전혈구계산 시장 규모, 점유율, 성장 분석 : 제품 유형별, 검사 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Complete Blood Count Market Size, Share, and Growth Analysis, By Product Type, By Test Type, By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 전혈구계산(CBC) 시장 규모는 2024년에 108억 4,000만 달러로 평가되며, 2025년 115억 7,000만 달러에서 2033년까지 194억 3,000만 달러로 확대되어, 예측 기간(2026-2033년) 동안 CAGR 6.7%로 성장할 것으로 전망됩니다.
세계 전혈구계산(CBC) 시장은 병원, 진료소, 검사 기관을 대상으로 혈액 검사 장비, 시약, 소프트웨어를 제공하는 제조사, 유통업체, 서비스 제공업체로 구성된 광범위한 네트워크로 이루어져 있습니다. CBC 검사는 빈혈, 감염증, 응고 장애 등의 질환을 진단하는 데 필수적이며, 가장 빈번하게 시행되는 검사입니다. 만성 질환 유병률의 상승과 인구 증가에 따라 시장은 현저히 발전하고 있으며, 신흥국에서는 농촌 지역 의료 현장을 위해 휴대용 분석 장비가 도입되고 있습니다. 데이터 분석 및 연결성 향상으로 인해 CBC 검사 결과의 임상적 유용성이 높아지고 있어, 기술 발전이 주요 성장 요인으로 작용하고 있습니다. 클라우드 기반 플랫폼은 환자의 상태를 실시간으로 모니터링할 수 있게 하여, 의료기기 기업의 투자를 유치하고 성과 연동형 의료비 상환 제도 개혁을 통해 수요를 견인함으로써 지속가능한 혁신을 촉진하는 환경을 조성하고 있습니다.
세계 전혈구계산(CBC) 시장의 성장요인
질병의 조기 발견에 대한 대중의 인식이 높아짐에 따라 정기적인 전혈구계산(CBC) 검사 수요가 크게 증가하고 있습니다. 이러한 추세에 따라 진료소들은 표준 건강검진에 CBC 검사를 포함시키기 시작했으며, 이를 통해 환자 기반을 확대하고 있습니다. 그 결과 검사 빈도가 증가했으며, 의료진은 CBC 결과를 활용하여 건강 상태의 추이를 모니터링하고 적시에 개입하고 있습니다. 또한, 보험사들은 예방 의료의 이점을 인식하고 있으며, 이에 따라 유리한 보험 적용 정책이 수립되고 있습니다. 이로 인해 진료소, 병원, 외래 진료 시설에서의 CBC 서비스 수요가 전 세계적으로 지속적으로 증가하고 있으며, 이는 시장 성장을 촉진하고 있습니다.
세계 전혈구계산(CBC) 시장의 제약요인
세계 전혈구계산(CBC) 시장은 첨단 CBC 분석기에 필요한 막대한 설비 투자로 인해 큰 과제에 직면해 있습니다. 많은 기관, 특히 제한된 예산으로 운영되는 소규모 검사실이나 진료소에서는 이러한 재정적 장벽으로 인해 어려움을 겪고 있습니다. 높은 비용으로 인해 경영진은 어려운 구매 결정을 내려야 하며, 필요한 장비 구입 자금을 확보하기 위해 필수적인 시스템 업그레이드가 종종 지연됩니다. 이러한 재정적 제약으로 인해 시장 침투가 제한되고, 잠재적 소비자가 충분한 자원을 확보할 때까지 도입이 미뤄집니다. 그 결과, 특히 혁신적인 진단 장비에 대한 접근성이 이미 제한된 개발도상국에서 시장 성장이 저해되고 있습니다.
세계 전혈구계산(CBC) 시장 동향
세계 전혈구계산(CBC) 시장에서는 현장진단 검사(POCT) 확대를 향한 뚜렷한 추세가 나타나고 있습니다. 이러한 분산형 진단으로의 전환에 따라 진료소, 응급의료센터, 재택 환경 등 다양한 현장에서 휴대용 CBC 분석기가 널리 채택되고 있습니다. 의료진은 결과를 즉시 확인할 수 있어 신속한 임상 판단이 가능해짐에 따라 이러한 기기를 점점 더 선호하고 있으며, 환자에게도 내원 시간 단축과 신속한 대응이라는 이점이 있습니다. 업계에서는 무선 데이터 전송, AI를 활용한 판정, 손쉬운 유지보수를 특징으로 하는 소형 기기의 개발이 진행되고 있으며, 이를 통해 시장 기회가 확대되는 동시에 맞춤형 의료 및 환자 치료 결과 개선에 대한 관심 증가와도 부합하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 전혈구계산 시장 규모 : 제품 유형별
세계의 전혈구계산 시장 규모 : 검사 유형별
세계의 전혈구계산 시장 규모 : 용도별
세계의 전혈구계산 시장 규모 : 최종사용자별
세계의 전혈구계산 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.08.28Global Complete Blood Count(Cbc) Market size was valued at USD 10.84 Billion in 2024 and is poised to grow from USD 11.57 Billion in 2025 to USD 19.43 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).
The global Complete Blood Count (CBC) market encompasses a wide network of manufacturers, distributors, and service providers offering hematology analyzers, reagents, and software to hospitals, clinics, and laboratories. CBC tests are essential for diagnosing conditions such as anemia, infections, and clotting disorders, making them the most frequently conducted tests. The market has evolved significantly due to the rising incidence of chronic diseases and population growth, with emerging economies adopting portable analyzers for rural healthcare. Technological advancements are key growth drivers, as data analytics and connectivity enhance the clinical utility of CBC results. Cloud-based platforms facilitate real-time monitoring of patient conditions, attracting investments from medical-device companies and driving demand through outcome-based care reimbursement reforms, fostering an environment of sustained innovation.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Complete Blood Count(Cbc) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Complete Blood Count(Cbc) Market Segments Analysis
Global complete blood count(cbc) market is segmented by product type, test type, application, end user and region. Based on product type, the market is segmented into hematology analyzers, reagents & consumables and controls & calibrators. Based on test type, the market is segmented into 3-part differential and 5-part differential. Based on application, the market is segmented into routine health screening, disease diagnosis and treatment monitoring. Based on end user, the market is segmented into hospitals, diagnostic laboratories and clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Complete Blood Count(Cbc) Market
The increasing public awareness surrounding early disease detection significantly boosts the demand for routine complete blood count (CBC) testing. This trend encourages clinics to integrate CBC panels into standard health assessments, thereby broadening their patient base. As a result, the frequency of testing rises, with healthcare professionals utilizing CBC results to monitor health trends and implement timely interventions. Furthermore, insurance companies acknowledge the benefits of preventive healthcare, leading to the development of favorable coverage policies. This, in turn, spurs market growth as demand for CBC services in clinics, hospitals, and ambulatory facilities continues to escalate on a global scale.
Restraints in the Global Complete Blood Count(Cbc) Market
The Global Complete Blood Count (CBC) market faces significant challenges due to the high capital investment required for advanced CBC analyzers. Many institutions, particularly small laboratories and clinics operating on tight budgets, struggle with this financial barrier. The steep costs compel management to make difficult purchasing decisions, often delaying essential system upgrades to allocate funds for necessary equipment. This financial constraint limits market penetration and postpones implementation for potential consumers until adequate resources are available. As a result, the market's growth is impeded, particularly in developing countries where access to innovative diagnostic equipment is already restricted.
Market Trends of the Global Complete Blood Count(Cbc) Market
The Global Complete Blood Count (CBC) market is witnessing a significant trend towards the expansion of Point-of-Care Testing (POCT). This shift towards decentralized diagnostics is leading to the widespread adoption of portable CBC analyzers across various settings, including clinics, urgent-care centers, and home environments. Healthcare providers are increasingly favoring these devices due to their ability to deliver instant results, facilitating faster clinical decisions, while patients benefit from reduced travel time and prompt responses. The industry is innovating with compact devices featuring wireless data transfer, AI-based interpretation, and easy maintenance, thus broadening market opportunities and aligning with the growing emphasis on personalized healthcare and enhanced patient outcomes.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Complete Blood Count(CBC) Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Hematology Analyzers
- Reagents & Consumables
- Controls & Calibrators
Global Complete Blood Count(CBC) Market Size by Test Type & CAGR (2026-2033)
- Market Overview
- 3-Part Differential
- 5-Part Differential
Global Complete Blood Count(CBC) Market Size by Application & CAGR (2026-2033)
- Market Overview
- Routine Health Screening
- Disease Diagnosis
- Treatment Monitoring
Global Complete Blood Count(CBC) Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Diagnostic Laboratories
- Clinics
Global Complete Blood Count(CBC) Market Size & CAGR (2026-2033)
- North America (Product Type, Test Type, Application, End User)
- US
- Canada
- Europe (Product Type, Test Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Test Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Test Type, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Test Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HORIBA, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mindray Bio-Medical Electronics Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boule Diagnostics AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Diatron MI Zrt.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EKF Diagnostics Holdings plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shenzhen Dymind Biotechnology Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Erba Mannheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DIRUI Industrial Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orphee SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Drew Scientific Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agappe Diagnostics Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioSystems S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Randox Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Analytik Jena GmbH+Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
